[
  {
    "ts": "2025-04-15T09:02:56+00:00",
    "headline": "Immuno-Oncology Stocks Q4 In Review: Exact Sciences (NASDAQ:EXAS) Vs Peers",
    "summary": "Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at Exact Sciences (NASDAQ:EXAS) and its peers.",
    "url": "https://finance.yahoo.com/news/immuno-oncology-stocks-q4-review-090256516.html",
    "source": "StockStory",
    "provider": "yfinance",
    "raw": {
      "id": "00cb5425-66d0-3a6b-bd39-3b3972947772",
      "content": {
        "id": "00cb5425-66d0-3a6b-bd39-3b3972947772",
        "contentType": "STORY",
        "title": "Immuno-Oncology Stocks Q4 In Review: Exact Sciences (NASDAQ:EXAS) Vs Peers",
        "description": "",
        "summary": "Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at Exact Sciences (NASDAQ:EXAS) and its peers.",
        "pubDate": "2025-04-15T09:02:56Z",
        "displayTime": "2025-04-15T09:02:56Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/stockstory_922/8bb4d6080e233d1f151e19de191abe64",
          "originalWidth": 1400,
          "originalHeight": 700,
          "caption": "EXAS Cover Image",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/xQ5Tn.rYMKJlL.qEUptKzA--~B/aD03MDA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/stockstory_922/8bb4d6080e233d1f151e19de191abe64.cf.webp",
              "width": 1400,
              "height": 700,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/14NEPyS5tV7XDXHg2_uQtw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/stockstory_922/8bb4d6080e233d1f151e19de191abe64.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "StockStory",
          "url": "https://stockstory.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/immuno-oncology-stocks-q4-review-090256516.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/immuno-oncology-stocks-q4-review-090256516.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "EXAS"
            },
            {
              "symbol": "NTRA"
            },
            {
              "symbol": "REGN"
            },
            {
              "symbol": "INCY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]